Healthcare Services

Neurotechnology Market Forecast Analysis Through 2030 With Insights On Industry Expansion

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Larger Will The Neurotechnology Market Become By 2030 Compared To 2026?

The neurotechnology market has observed substantial growth in recent years. Its valuation is anticipated to rise from $17.34 billion in 2025 to $19.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.4%. This past expansion is attributable to breakthroughs in medical imaging technologies, the initial integration of neurostimulation therapies, an uptick in clinical research concerning neurology, the escalating occurrence of neurological disorders, and continuous technological advancements in implantable devices.

The neurotechnology market size is poised for significant expansion over the forthcoming years. This market is projected to reach $33.64 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.1%. This expansion during the forecast period stems from escalating investment in brain-computer interfaces, heightened demand for individualized neurological treatments, the broadening application of AI-driven diagnostics, increasing uptake of home-based neurotechnology, and the emergence of minimally invasive neurotherapies. Key trends for the forecast period encompass the broadening of brain-computer interface solutions, increased uptake of non-invasive neurostimulation devices, deeper integration of neuroimaging in clinical diagnostics, a rising need for cognitive rehabilitation technologies, and improvements in neurological implant materials.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9840&type=smp

Which Growth Factors Are Strengthening The Neurotechnology Market Landscape?

The increasing occurrence of neurological conditions is anticipated to drive the expansion of the neurotechnology market going forward. A neurological condition refers to any disorder or disease affecting the brain, with common examples including Alzheimer’s disease, Parkinson’s disease, epilepsy, and migraine. Neurotechnology is utilized for diagnosing and treating neurological disorders through various methods such as brain imaging, neurostimulation, neurofeedback, and brain-computer interfaces. For instance, in October 2023, the World Federation of Neurology, a UK-based charity, reported that neurological disorders now constitute the second-leading cause of death and the primary cause of disability worldwide, reflecting an accelerating global health burden. The report also stated that more than 40 percent of the global population was affected in 2023, and the number of individuals living with brain disease is projected to nearly double by 2050. Therefore, the heightened prevalence of neurological conditions is propelling the growth of the neurotechnology market going forward.

How Is The Neurotechnology Market Examined Through Segment Analysis?

The neurotechnology market covered in this report is segmented –

1) By Conditions: Cognitive Disorders, Pain Treatment, Urinary And Fecal Incontinence, Epilepsy, Parkinson’s Disease, Hearing Conditions, Sleep Disorder, Depression, Other Conditions

2) By Type: Imaging Modalities, Neurostimulation, Cranial Surface Measurement, Neurological Implants, Other Types

3) By End Use: Ambulatory Surgical Centers, Hospitals, Homecare Facilities, Other End Uses

Subsegments:

1) By Cognitive Disorders: Alzheimer’s Disease, Attention Deficit Hyperactivity Disorder (ADHD), Dementia

2) By Pain Treatment: Chronic Pain, Neuropathic Pain, Acute Pain

3) By Urinary And Fecal Incontinence: Overactive Bladder, Neurogenic Bladder, Fecal Incontinence Management

4) By Epilepsy: Drug-Resistant Epilepsy, Seizure Management Devices

5) By Parkinson’s Disease: Motor Symptoms Management, Non-Motor Symptoms Management

6) By Hearing Conditions: Tinnitus, Hearing Loss Solutions

7) By Sleep Disorder: Insomnia, Sleep Apnea, Restless Legs Syndrome

8) By Depression: Major Depressive Disorder, Treatment-Resistant Depression

9) By Other Conditions: Anxiety Disorders, Autism Spectrum Disorder, Traumatic Brain Injury (TBI)

What Trends Are Influencing The Neurotechnology Market Outlook?

Major companies operating in the neuroscience market are concentrating their efforts on developing innovative technologies such as artificial intelligence and machine learning to drive advancements in neuroscience. Artificial intelligence enables machines to replicate and even surpass human mental powers, with machine learning being a component of artificial intelligence. Artificial intelligence (AI) models are constructed to perform intelligence-based tasks that are offering new insights into how these processes are regulated within the brain. For instance, in February 2024, Koninklijke Philips N.V., a Netherlands-based technology company, and Synthetic MR, a Sweden-based MRI software company, launched Smart Quant Neuro 3D, a groundbreaking tool for diagnosing and assessing brain disorders like multiple sclerosis, traumatic brain injury, and dementia. This solution integrates Philips’ AI-based SmartSpeed technology, 3D SyntAc application, and Synthetic MR’s SyMRI NEURO 3D software, providing healthcare providers with enhanced diagnostic capabilities for greater confidence and improved patient outcomes. Philips holds exclusive rights to offer SyMRI NEURO 3D on its MR scanners.

Who Are The Businesses Driving Activity In The Neurotechnology Market?

Major companies operating in the neurotechnology market are General Electric, Medtronic PLC, Koninklijke Philips N.V., Shimadzu Corporation, Elekta AB, Natus Medical Incorporated, Abbott, Boston Scientific Corporation, Nihon Kohden Corporation, LivaNova PLC, Siemens Healthcare Private Limited, Hitachi Medical Corporation, Cochlear Limited, NeuroPace Inc., NeuroSigma Inc., NeuroMetrix Inc., NeuroSky Inc., NeuroVigil Inc., Neurotech Pharmaceuticals Inc., Neuralink, Synchron Inc., Blackrock Neurotech, Neuronetics Inc., Neurable Inc.

Access The Complete Neurotechnology Market Report:

https://www.thebusinessresearchcompany.com/report/neurotechnology-global-market-report

Which Region Stands As The Largest Contributor To The Neurotechnology Market?

North America was the largest region in the neurotechnology market in 2025. Europe is expected to be the fastest-growing region in the neurotechnology market report during the forecast period. The regions covered in the neurotechnology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Neurotechnology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=9840&type=smp

Browse Through More Reports Similar to the Global Neurotechnology Market 2026, By The Business Research Company

Neurotechnology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurotechnology-global-market-report

Neuroprosthetics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuroprosthetics-global-market-report

Nephrologists Market Global Report 2020 2030 Covid 19 Implications And Growth 2026

https://www.thebusinessresearchcompany.com/report/nephrologists-market-global-report-2020-2030-covid-19-implications-and-growth

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795